Evidence map›Paper›PMID 28405880›Full record

ArticleEndocrine2017

STEAP4 expression in human islets is associated with differences in body mass index, sex, HbA1c, and inflammation.

Hannah M Gordon, Neil Majithia, Patrick E MacDonald, Jocelyn E Manning Fox, Poonam R Sharma, Frances L Byrne, Kyle L Hoehn, Carmella Evans-Molina, Linda Langman, Kenneth L Brayman and 1 more

Open access · greenAbstract read
In one paragraph

Article in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Hannah M GordonDepartment of Biomedical Sciences, Ohio University, Athens, OH, USA.
Neil MajithiaDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Patrick E MacDonaldAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, AB, T6G 2R3, Canada.
Jocelyn E Manning FoxAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, AB, T6G 2R3, Canada.
Poonam R SharmaDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Frances L ByrneSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Kyle L HoehnSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Carmella Evans-MolinaDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Linda LangmanDepartment of Surgery, University of Virginia Health System, Charlottesville, VA, USA.
Kenneth L BraymanDepartment of Surgery, University of Virginia Health System, Charlottesville, VA, USA.
Craig S NunemakerDepartment of Biomedical Sciences, Ohio University, Athens, OH, USA. nunemake@ohio.edu.ORCID http://orcid.org/0000-0003-2894-3388
Ohio University · USUniversity of Alberta · CAUniversity of Virginia · USUniversity of Virginia Health System · USUNSW Sydney · AURichard L. Roudebush VA Medical Center · US

Funding

Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Carmella Evans-Molina · 2015 to 2026
$17.4M
Mechanisms of Beta Cell Function in Health and DiseaseR01DK093954 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2011 to 2019
$3.5M
Low-grade Inflammation, Cytokines, and Beta-Cell Dysfunction in Type 2 DiabetesR01DK089182 · NIDDK · UNIVERSITY OF VIRGINIA · PI NUNEMAKER, CRAIG S · 2011 to 2015
$1.6M
ACC enzymes and protein acetylationR01DK101803 · NIDDK · UNIVERSITY OF VIRGINIA · PI HOEHN, KYLE LEE · 2014 to 2017
$1.4M
Regulation of Calcium Homeostasis in the Pancreatic Beta CellI01BX001733 · VA · RLR VA MEDICAL CENTER · PI Carmella Evans-Molina · 2013 to 2026
–
BLRD VA I01 BX001733NIDDK NIH HHS P30 DK097512NIDDK NIH HHS R01 DK089182NIDDK NIH HHS R01 DK093954NIDDK NIH HHS R01 DK101803
6 · The paper itself

Abstract

objectiveSTEAP4 (six-transmembrane epithelial antigen of the prostate 4) is a metalloreductase that has been shown previously to protect cells from inflammatory damage. Genetic variants in STEAP4 have been associated with numerous metabolic disorders related to obesity, including putative defects in the acute insulin response to glucose in type 2 diabetes. PURPOSE: We examined whether obesity and/or type 2 diabetes altered STEAP4 expression in human pancreatic islets.

methodsHuman islets were isolated from deceased donors at two medical centers and processed for quantitative polymerase chain reaction. Organ donors were selected by status as non-diabetic or having type 2 diabetes. Site 1 (Edmonton): N = 13 type 2 diabetes donors (7M, 6F), N = 20 non-diabetic donors (7M, 13F). Site 2 (Virginia): N = 6 type 2 diabetes donors (6F), N = 6 non-diabetic donors (3M, 3F).

resultsSTEAP4 showed reduced islet expression with increasing body mass index among all donors (P < 0.10) and non-diabetic donors (P < 0.05) from Site 1; STEAP4 showed reduced islet expression among type 2 diabetes donors with increasing hemoglobin A1c. Islet STEAP4 expression was also marginally higher in female donors (P < 0.10). Among type 2 diabetes donors from Site 2, islet insulin expression was reduced, STEAP4 expression was increased, and white blood cell counts were increased compared to non-diabetic donors. Islets from non-diabetic donors that were exposed overnight to 5 ng/ml IL-1β displayed increased STEAP4 expression, consistent with STEAP4 upregulation by inflammatory signaling.

conclusionsThese findings suggest that increased STEAP4 mRNA expression is associated with inflammatory stimuli, whereas lower STEAP4 expression is associated with obesity in human islets. Given its putative protective role, downregulation of STEAP4 by chronic obesity suggests a mechanism for reduced islet protection against cellular damage.

Indexed as

Body Mass IndexAdultAgedDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansInflammationIslets of LangerhansMaleMembrane ProteinsMiddle AgedObesityOxidoreductasesSex FactorsGlycated Hemoglobinhemoglobin A1c protein, humanMembrane ProteinsOxidoreductasesSTEAP4 protein, humanCytokinesInflammationIronIsletsObesityType 2 diabetes

Identifiers

PMID28405880
PMCPMC6166871
OpenAlexW2607442282

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.